3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Uveal Melanoma
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Mouth Neoplasms
1
Lymphangioleiomyomatosis
1
Erdheim-Chester Disease
1
Endocrine Gland Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
12
Vincristine
9
Etoposide
8
venetoclax
6
Methotrexate
6
Doxorubicin
6
Dexamethasone
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
prednylidene
4
pegaspargase
4
merphos
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
deltacortene
4
calaspargase pegol
4
auricularum
4
Specimen Handling
4
Granulocyte Colony-Stimulating Factor
4
fludarabine phosphate
3
daratumumab
3
Thioguanine
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mercaptopurine
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Hydrocortisone
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Valproic Acid
×
90 days
×
Clear all
No trials found.